Article 12 Criteria for determining simplified procedures for export authorisationsF1
United Kingdom
Following an application by the operator concerned the competent authority may grant an export authorisation by simplified procedure pursuant to Article 19 of Regulation (EC) No 111/2005 in cases of frequent exports of one specific scheduled substance listed in Categories 3 and 4 of the Annex to that Regulation involving the same exporter established in F2Great Britain and the same importer in the same third country of destination F3or Northern Ireland covering a specific time period of either 6 or 12 months.
Such simplified export authorisation may only be granted in the following cases:
where during previous exports the operator has shown the capacity to fulfil all obligations in relation to those exports, and has not committed any offences against relevant legislation;
where the competent authority can satisfy itself as to the licit purposes of those export operations.
The application for a simplified export authorisation shall contain at least the following:
the names and addresses of the exporter, the importer in the third country F4or Northern Ireland, and the ultimate consignee;
the name of the scheduled substance, as stated in the Annex to Regulation (EC) No 111/2005, or, in the case of a mixture or natural product, its name and CN code and the name of any scheduled substance, as stated in the Annex to Regulation (EC) No 111/2005, contained in the mixture or natural product;
the maximum quantity of the scheduled substance intended for export;
the intended specific time period for the export operations.
The competent authority shall take the decision on the application for simplified export authorisation within a period of 15 working days from the date on which it received the required information.
In case of emergency medical care, where the conditions under paragraph 1 (a) and (b) of this Article are fulfilled, the competent authority shall take the decision on the application for simplified export authorisation for exports of scheduled substances of Category 4 listed in the Annex to Regulation (EC) No 111/2005 immediately or at the latest within 3 working days after receipt of the application.
Annotations
Textual amendments
- F1
Regulation revoked (N.I.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), reg. 1(1), Sch.
- F2
Words in Art. 12(1) substituted (E.W.S.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 7(7)(a)(i)
- F3
Words in Art. 12(1) inserted (E.W.S.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 7(7)(a)(ii)
- F4
Words in Art. 12(2)(a) inserted (E.W.S.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 7(7)(b)